Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1991 Jan;33(1):45–49. doi: 10.1007/BF01742527

Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

Peter Wersäll 1, Giuseppe Masucci 1, Håkan Mellstedt 1,✉
PMCID: PMC11037951  PMID: 2021957

Abstract

Human peripheral blood mononuclear cells (lymphocytes and monocytes) (PBMC) were preincubated for 0–24 h with human recombinant interleukin-4 (IL-4) and used as effector cells in an 18 h antibody-dependent cellular cytotoxicity (ADCC) assay with mAb 17-1A (mouse IgG2A) against SW948 (a human colorectal carcinoma cell line). A statistically significant increase in the lytic capability was noted after 2–24 h of preactivation. IL-4 at 1 ng/ml induced the highest cell lysis while higher and lower concentrations were inferior or had no effect at all. Preactivation for 24 h induced a more effective lytic cell population than 2 h prestimulation: 63 LU (lytic units)/106 cells vs 42 LU/106 cells. Pretreatment with 1 ng/ml IL-4 for 2 h induced a statistically significant increase in the ADCC activity of PBMC (P <0.05), of monocytes (P <0.01) and E-rosette-negative cells (natural killer cells) (P <0.05) compared to non-activated cells. IL-4 did not induce lymphokine-activated killer activity of PBMC against SW948. The spontaneous cytotoxicity against K562 was, however, increased after stimulation with 1 ng/ml IL-4 for 2 h of E-rosette-negative non-adherent cells.

Key words: IL-4, ADCC, Monoclonal antibodies

References

  • 1.Adams DO, Hall T, Steplewski Z, Koprowski H. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotope contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci USA. 1984;81:3506. doi: 10.1073/pnas.81.11.3506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bøyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol. 1983;17:429. doi: 10.1111/j.1365-3083.1983.tb00809.x. [DOI] [PubMed] [Google Scholar]
  • 3.Coffman RL, Ohara J, Bond MW, Cartz J, Zlotnik A, Paul WE. B-cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol. 1986;136:4538. [PubMed] [Google Scholar]
  • 4.Crawford RM, Finbloom DS, Ohara J, Paul WE, Meltzer MS. B-cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol. 1987;139:135. [PubMed] [Google Scholar]
  • 5.Fanger MW, Shen L, Graziano RF, Guyre PM. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today. 1989;10:92. doi: 10.1016/0167-5699(89)90234-X. [DOI] [PubMed] [Google Scholar]
  • 6.Fernandez-Botran R, Sanders VM, Oliver K, Chen YW, Krammer PH, Uhr JW, Vitetta ES. Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. Proc Natl Acad Sci USA. 1986;83:9689. doi: 10.1073/pnas.83.24.9689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Frödin J-E, Pihlstedt P, Lefvert A-K, Mellstedt H. Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatment. Hybridoma. 1987;6:555. doi: 10.1089/hyb.1987.6.555. [DOI] [PubMed] [Google Scholar]
  • 8.Herlyn D, Herlyn M, Steplewski Z, Koprowski H. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol. 1979;9:657. doi: 10.1002/eji.1830090817. [DOI] [PubMed] [Google Scholar]
  • 9.Janson CH, Tehrani MJ, Mellstedt H, Wigzell H. Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy. Cancer Immunol Immunother. 1989;28:225. doi: 10.1007/BF00204993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur J Immunol. 1973;3:645. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  • 11.Johnson W, Steplewski Z, Matthews TJ, Hamilton T, Koprowski H, Adams D. Cytolytic interaction between murine macrophages, tumor cells and monoclonal antibodies: characterization of lytic condition and requirements for effector activation. J Immunol. 1986;136:4704. [PubMed] [Google Scholar]
  • 12.Kawakami Y, Rosenberg SA, Lotze MT. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med. 1988;168:2183. doi: 10.1084/jem.168.6.2183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kawakami Y, Custer MC, Rosenberg SA, Lotze MT. IL-4 regulates IL-2 induction of lymphokine activated killer activity from human lymphocytes. J Immunol. 1989;142:3452. [PubMed] [Google Scholar]
  • 14.Lindemalm C, Mellstedt H, Biberfeld P, Björkholm M, Christensson B, Holm G, Johansson B, Sundblad R. Blood and lymph node T lymphocyte subsets in non-Hodgkin lymphomas. Scand J Haematol. 1983;30:68. doi: 10.1111/j.1600-0609.1983.tb00636.x. [DOI] [PubMed] [Google Scholar]
  • 15.Ljunggren HD, Kärre K. In search of the “missing self”: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237. doi: 10.1016/0167-5699(90)90097-s. [DOI] [PubMed] [Google Scholar]
  • 16.Lundgren G, Zukoski CF, Möller G. Differential effects of human granulocytes and lymphocytes on human fibroblasts. Clin Exp Immunol. 1968;3:817. [PMC free article] [PubMed] [Google Scholar]
  • 17.Masucci G, Masucci MG, Klein E. Human blood lymphocyte subsets separated on the basis of nylon adherence, SRBC and EA rosetting: natural cytotoxicity and characterization with monoclonal reagents. Cell Immunol. 1982;69:166. doi: 10.1016/0008-8749(82)90060-0. [DOI] [PubMed] [Google Scholar]
  • 18.Masucci G, Lindemalm C, Frödin J-E, Hagström B, Mellstedt H. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948) Hybridoma. 1988;7:429. doi: 10.1089/hyb.1988.7.429. [DOI] [PubMed] [Google Scholar]
  • 19.Masucci G, Wersäll P, Ragnhammar P, Mellstedt H. GM-CSF augments the cytotoxic capacity of lymphocytes and monocytes in antibody dependent cellular cytotoxicity (ADCC) Cancer Immunol Immunother. 1989;29:288. doi: 10.1007/BF00199217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mitchell LC, Davis LS, Lipsky PE. Promotion of human T lymphocyte proliferation by IL-4. J Immunol. 1989;142:1548. [PubMed] [Google Scholar]
  • 21.Mosmann TR, Bond MW, Coffman RL, Ohara J, Paul WE. T cell and mast cell lines respond to B cell stimulatory factor 1. Proc Natl Acad Sci USA. 1986;83:5654. doi: 10.1073/pnas.83.15.5654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vitetta ES, Brooks K, Chen YW, Isaksson P, Jones S, Layton J, Mishra GC, Pure E, Weiss E, Word C. T cell derived lymphokines that induce IgM and IgG secretion in activated murine B cells. Immunol Rev. 1984;78:137. doi: 10.1111/j.1600-065x.1984.tb00480.x. [DOI] [PubMed] [Google Scholar]
  • 23.Mule JJ, Krosnick JA, Rosenberg SA. IL-4 regulation of murine lymphokine activated killer activity in vitro. Effects on the IL-2 induced expansion, cytotoxicity and phenotype of lymphokine activated killer effectors. J Immunol. 1989;142:726. [PubMed] [Google Scholar]
  • 24.Nagler A, Lanier LL, Phillips JH. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol. 1988;141:2349. [PubMed] [Google Scholar]
  • 25.Noelle R, Krammer PH, Ohara J, Uhr JW, Vitetta ES. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc Natl Acad Sci USA. 1984;81:6149. doi: 10.1073/pnas.81.19.6149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ortaldo J, Woodhouse C, Morgan AC, Herberman R, Cheresh D, Reisfeld R. Analysis of effectors in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol. 1987;138:3566. [PubMed] [Google Scholar]
  • 27.Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA. IL-4 induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. J Immunol. 1988;140:3679. [PubMed] [Google Scholar]
  • 28.Pfeifer JD, McKenzie DT, Swain S, Dutton RW. B-cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Exp Med. 1987;166:1464. doi: 10.1084/jem.166.5.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Schulz G, Staffileno LK, Reisfeld RA, Dennert G. Eradication of established human melanoma tumor in nude mice by antibody-directed effector cells. J Exp Med. 1985;161:1315. doi: 10.1084/jem.161.6.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shetye J, Frödin J-E, Christensson B, Grant C, Jacobsson B, Sundelius S, Sylvén M, Biberfeld P, Mellstedt H. Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated withmonoclonal antibodies (mAb 17-1A) Cancer Immunol Immunother. 1988;27:154. doi: 10.1007/BF00200021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE. IL-4 inhibits IL-2 mediated induction of human lymphokine activated killer cells but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol. 1988;141:29. [PubMed] [Google Scholar]
  • 32.Velde AA, Klomp JPG, Yard BA, de Vries JE, Figdor CG. Modulation of phenotypic and funcional properties of human peripheral blood monocytes by IL-4. J Immunol. 1988;140:1548. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES